L
Locanabio, Inc.
LCNBHealth Care· Woburn, Massachusetts, US
LAYOFFS TRACKED
1
LAST EVENT
Dec 31, 2023
MARKET CAP
$273.41M
as of Aug 26, 2026
EMPLOYEES
20
Locanabio, Inc. is a clinical-stage biotechnology company focused on developing small molecule therapies that target RNA and protein pathways to treat cancer and other serious diseases. The company advances a pipeline of orally bioavailable drug candidates designed to modulate previously undruggable targets.
Layoff timeline
1 EVENTStories from here
No one has shared a story from Locanabio yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Locanabio
We'll email you the moment a new layoff is reported here.